PERi-operative Selective Decontamination of the digestive tract to prevent severe infectious complications after Esophageal Resection: study protocol of the PERSuaDER-trial, a multicenter randomized controlled trial in patients with primary resectabl
The PERSuaDER trial is registered in ClinicalTrials.gov (NCT05865743) and the European Clinical Trials Information System (CTIS) (EU Trial number: 2023-504144-33), Trial authorization date: 25.03.2024, protocol version 1.1, date: 03.03.2024.
Authors
- Marjan de Vries (ORCID: https://orcid.org/0000-0002-8103-2623)
- Jeroen Schouten (ORCID: https://orcid.org/0000-0001-9118-4420)
- Camiel Rosman (ORCID: https://orcid.org/0000-0002-9152-3987)
- Hans Van Veer (ORCID: https://orcid.org/0000-0003-1153-8298)
- Cornelis H. van Werkhoven (ORCID: https://orcid.org/0000-0002-0626-4635)
- Bastiaan R. Klarenbeek (ORCID: https://orcid.org/0000-0003-2178-8557)
- Justin G. A. Grootenhuis (ORCID: https://orcid.org/0009-0002-4992-6683)
- Sander Ubels (ORCID: https://orcid.org/0000-0002-9649-5436)
- Linda M. Garms (ORCID: https://orcid.org/0000-0002-5121-7766)
- Ward Seurs (ORCID: https://orcid.org/0009-0002-0500-4329)
Institutions
- Radboud University Nijmegen (NL)
- Utrecht University (NL)
- Radboud University Medical Center (NL)
- University Medical Center Utrecht (NL)
- Radboud Institute for Molecular Life Sciences (NL)
- Canisius-Wilhelmina Ziekenhuis (NL)
- KU Leuven (BE)
Publication Details
- Journal
- Trials
- Published
- 2025-12-04
- DOI
- https://doi.org/10.1186/s13063-025-09311-w
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00